Biogen · 4 months ago
Associate Director, Corporate Strategy, New Businesses & Integration
Cambridge, MA
Full-time
Onsite
Senior Level, Lead/Staff
$156K/yr - $215K/yr
10+ years expBiogen is a mid-sized biotechnology company committed to excellence and innovation in life-changing medicines. The Associate Director, Corporate Strategy, New Businesses & Integration will lead commercial due diligence and drive competitive intelligence to support the company's strategic direction and portfolio optimization.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Lead commercial due diligence efforts on new therapeutic areas and markets by conducting market research, building revenue and operating expense forecasts, and developing market models ranging from structured scenario analyses to advanced probabilistic simulations (e.g., Monte Carlo)
Drive enterprise-wide competitive intelligence by conducting qualitative assessments of peer companies paired with quantitative benchmarking to generate actionable insights and strategic implications
Support portfolio optimization and capital allocation by applying quantitative analytics — including internal and external benchmarking, resource allocation algorithms, and scenario-based sensitivity analysis
Collaborate with senior leaders across regions and functions to create business cases and investment recommendations, supported by rigorous analytics and clear strategic rationale
Enhance the capabilities of the CS&NBI team by integrating best practices in analytical methodologies, decision-making frameworks, and cross-functional collaboration
Develop custom analog libraries that integrate internal performance data with external benchmarks to guide opportunities evaluations, scenario planning, and portfolio decision making
Qualification
Required
10+ years of professional experience ideally in Life Sciences, or at least 5 years of relevant experience in commercial, consulting, or strategy roles within the Life Sciences sector is required
Extensive experience leading commercial due diligence efforts with a proven ability to conduct rigorous market research, develop detailed revenue and expense forecasts, and build market models—such as patient flow models, structured scenario analyses, and probabilistic simulations (e.g., Monte Carlo)
Skilled in conducting enterprise-level competitive intelligence through qualitative analysis and quantitative benchmarking to provide actionable insights and strategic recommendations
Experienced in using advanced portfolio management methodologies, such as resource allocation algorithms and sensitivity analyses, to evaluate investment trade-offs
Proven ability to distill complex analyses into clear, compelling and objective recommendations for senior leadership and board-level audiences
A track record of navigating and influencing across matrixed organizations, driving alignment among senior leaders, and fostering collaboration across regions and functions
Benefits
Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Founded in 1978Cambridge, Massachusetts, USA
5001-10000 employees
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Robin C. Kramer
Executive Vice President, Chief Financial Officer
Priya Singhal
Executive Vice President, Head of Development
Recent News
2026-01-13
Company data provided by crunchbase